Common Stock, Shares Authorized of Inhibrx Biosciences, Inc. from Q4 2023 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Inhibrx Biosciences, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2023 to Q3 2025.
  • Inhibrx Biosciences, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2025 was 120M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)

Inhibrx Biosciences, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 120M 0 0% Sep 30, 2025 10-Q 2025-11-14
Q2 2025 120M 0 0% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 120M Mar 31, 2025 10-Q 2025-05-14
Q4 2024 120M 0 0% Dec 31, 2024 10-Q 2025-11-14
Q3 2024 120M Sep 30, 2024 10-Q 2024-11-14
Q2 2024 120M Jun 30, 2024 10-Q 2024-08-13
Q4 2023 120M Dec 31, 2023 10-K 2025-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.